HK1193407A1 - Pyrrolidine-3-ylacetic acid derivative -3- - Google Patents
Pyrrolidine-3-ylacetic acid derivative -3-Info
- Publication number
- HK1193407A1 HK1193407A1 HK14106800.1A HK14106800A HK1193407A1 HK 1193407 A1 HK1193407 A1 HK 1193407A1 HK 14106800 A HK14106800 A HK 14106800A HK 1193407 A1 HK1193407 A1 HK 1193407A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyrrolidine
- acid derivative
- ylacetic acid
- ylacetic
- derivative
- Prior art date
Links
- OUENRUZPZZFMCA-UHFFFAOYSA-N 2-pyrrolidin-1-ium-3-ylacetate Chemical class OC(=O)CC1CCNC1 OUENRUZPZZFMCA-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2011199482 | 2011-09-13 | ||
| PCT/JP2012/073171 WO2013039057A1 (fr) | 2011-09-13 | 2012-09-11 | Dérivé de l'acide pyrrolidin-3-ylacétique |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1193407A1 true HK1193407A1 (en) | 2014-09-19 |
Family
ID=47883287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14106800.1A HK1193407A1 (en) | 2011-09-13 | 2014-07-04 | Pyrrolidine-3-ylacetic acid derivative -3- |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP2757103B1 (fr) |
| JP (1) | JP5829689B2 (fr) |
| KR (1) | KR101963922B1 (fr) |
| CN (1) | CN103764648B (fr) |
| AR (1) | AR087788A1 (fr) |
| AU (1) | AU2012309556B2 (fr) |
| BR (1) | BR112014004267B1 (fr) |
| CA (1) | CA2844617C (fr) |
| CL (1) | CL2014000484A1 (fr) |
| CY (1) | CY1117460T1 (fr) |
| DK (1) | DK2757103T3 (fr) |
| ES (1) | ES2564732T3 (fr) |
| HK (1) | HK1193407A1 (fr) |
| HR (1) | HRP20160166T1 (fr) |
| HU (1) | HUE026824T2 (fr) |
| IL (1) | IL230804A (fr) |
| JO (1) | JO3082B1 (fr) |
| ME (1) | ME02383B (fr) |
| MX (1) | MX358494B (fr) |
| MY (1) | MY169869A (fr) |
| PE (1) | PE20141353A1 (fr) |
| PL (1) | PL2757103T3 (fr) |
| PT (1) | PT2757103E (fr) |
| RS (1) | RS54582B1 (fr) |
| RU (1) | RU2615135C2 (fr) |
| SG (1) | SG11201400163WA (fr) |
| SI (1) | SI2757103T1 (fr) |
| SM (1) | SMT201600071B (fr) |
| TW (1) | TWI543975B (fr) |
| UA (1) | UA112873C2 (fr) |
| WO (1) | WO2013039057A1 (fr) |
| ZA (1) | ZA201400918B (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2900926A1 (fr) * | 2013-03-12 | 2014-09-18 | Eisai R&D Management Co., Ltd. | Sel de derive d'acide pyrrolidin-3-yl acetique et cristaux correspondants |
| WO2014142086A1 (fr) * | 2013-03-13 | 2014-09-18 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Dérivé acétate de pyrrolidin-3-yle et dérivé d'acétate de piperidin-3-yle |
| US20240199558A1 (en) | 2022-10-19 | 2024-06-20 | Astrazeneca Ab | 2,4,6-trisubstituted 1,3,5-triazines as modulators of cx3cr1 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4263391B2 (ja) | 2001-03-19 | 2009-05-13 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 抗ｃｘ３ｃｒ１抗体、抗フラクタルカイン抗体及びフラクタルカインの利用 |
| AU2002363236A1 (en) * | 2001-10-30 | 2003-05-12 | Millennium Pharmaceuticals, Inc. | Compounds, pharmaceutical compositions and methods of use therefor |
| US20070142386A1 (en) * | 2003-10-07 | 2007-06-21 | Astrazeneca | New 2-substituted, 4-amino-thiazolo[4,5-d] pyrimidines, useful as chemokine receptor antagonists, esp. cx3cr1 |
| AR053347A1 (es) * | 2005-04-06 | 2007-05-02 | Astrazeneca Ab | Derivados de [1,3]tiazolo[4,5-d]pirimidin-2(3h)-ona 5,7-sustituidos |
| UA90707C2 (en) | 2005-04-06 | 2010-05-25 | Астразенека Аб | Novel 5-substituted 7-amino-[1,3]thiazolo[4,5-d]pyrimidine derivatives |
| CA2664930A1 (fr) | 2006-09-29 | 2008-04-03 | Astrazeneca Ab | Nouveaux derives de [1, 3 ]thiazolo[4, 5-d]pyrimidine-2(3h)-amine 5,7-disubstitutes et leur utilisation en therapie |
| TW200820973A (en) | 2006-09-29 | 2008-05-16 | Astrazeneca Ab | Novel compounds 480 |
| AR063275A1 (es) * | 2006-10-12 | 2009-01-14 | Epix Delaware Inc | Compuestos de carboxamida, una composicion farmaceutica que los comprende y su uso en la preparacion de un medicamento para el tratamiento de enfermedades mediadas por la activacion de ccr2. |
| DK2262777T3 (en) * | 2008-03-07 | 2016-05-17 | Acraf | 1-benzyl-3-hydroxymetylindazolderivater and their use in the treatment of diseases based on the expression of MCP-1 and CX3CR1 |
| AR071036A1 (es) | 2008-03-26 | 2010-05-19 | Astrazeneca Ab | Derivados 5, 7-disustituidos de [1, 3]tiazolo[4, 5-d]pirimidin-2 (3h)-ona, una composicion farmaceutica que los comprende y su uso en el tratamiento de enfermedades mediadas por el receptor cx3cr1. |
-
2012
- 2012-09-05 JO JOP/2012/0251A patent/JO3082B1/ar active
- 2012-09-05 TW TW101132401A patent/TWI543975B/zh not_active IP Right Cessation
- 2012-09-06 AR ARP120103280A patent/AR087788A1/es active IP Right Grant
- 2012-09-11 MY MYPI2014700213A patent/MY169869A/en unknown
- 2012-09-11 AU AU2012309556A patent/AU2012309556B2/en not_active Ceased
- 2012-09-11 SI SI201230463T patent/SI2757103T1/sl unknown
- 2012-09-11 MX MX2014002210A patent/MX358494B/es active IP Right Grant
- 2012-09-11 CA CA2844617A patent/CA2844617C/fr active Active
- 2012-09-11 EP EP12831085.1A patent/EP2757103B1/fr active Active
- 2012-09-11 DK DK12831085.1T patent/DK2757103T3/en active
- 2012-09-11 JP JP2013533669A patent/JP5829689B2/ja active Active
- 2012-09-11 PT PT128310851T patent/PT2757103E/pt unknown
- 2012-09-11 BR BR112014004267-5A patent/BR112014004267B1/pt not_active IP Right Cessation
- 2012-09-11 SG SG11201400163WA patent/SG11201400163WA/en unknown
- 2012-09-11 RS RS20160106A patent/RS54582B1/en unknown
- 2012-09-11 PE PE2014000266A patent/PE20141353A1/es active IP Right Grant
- 2012-09-11 RU RU2014107536A patent/RU2615135C2/ru active
- 2012-09-11 CN CN201280041634.0A patent/CN103764648B/zh active Active
- 2012-09-11 PL PL12831085T patent/PL2757103T3/pl unknown
- 2012-09-11 WO PCT/JP2012/073171 patent/WO2013039057A1/fr active Application Filing
- 2012-09-11 KR KR1020147003630A patent/KR101963922B1/ko active IP Right Grant
- 2012-09-11 ES ES12831085.1T patent/ES2564732T3/es active Active
- 2012-09-11 HU HUE12831085A patent/HUE026824T2/en unknown
- 2012-09-11 ME MEP-2016-37A patent/ME02383B/fr unknown
- 2012-11-09 UA UAA201401661A patent/UA112873C2/uk unknown
-
2014
- 2014-02-03 IL IL230804A patent/IL230804A/en active IP Right Grant
- 2014-02-06 ZA ZA2014/00918A patent/ZA201400918B/en unknown
- 2014-02-27 CL CL2014000484A patent/CL2014000484A1/es unknown
- 2014-07-04 HK HK14106800.1A patent/HK1193407A1/xx not_active IP Right Cessation
-
2016
- 2016-02-16 HR HRP20160166TT patent/HRP20160166T1/hr unknown
- 2016-03-10 SM SM201600071T patent/SMT201600071B/xx unknown
- 2016-03-16 CY CY20161100224T patent/CY1117460T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3424953T3 (en) | Terapeutiske antistoffer | |
| EP2790561A4 (fr) | Lave-vaisselle | |
| EP2755962A4 (fr) | Azaindazoles | |
| EP2715659A4 (fr) | Überfeed | |
| EP2754063A4 (fr) | Extensibilité du protocole smb2 | |
| EP2723631A4 (fr) | Catamaran à quatre ailes portantes | |
| EP2776444A4 (fr) | Dihydroptéridinones | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| EP2695208A4 (fr) | Micro-thermocouple | |
| EP2679138A4 (fr) | Endoscope | |
| EP2708561A4 (fr) | Bio-aiguille | |
| GB201111742D0 (en) | Solution | |
| DK2770906T3 (en) | Applanationstonometer | |
| EP2684382A4 (fr) | Capuchon d'écouteur | |
| HK1193407A1 (en) | Pyrrolidine-3-ylacetic acid derivative -3- | |
| EP2698098A4 (fr) | Campimètre | |
| EP2694655A4 (fr) | pAVEC | |
| EP2702929A4 (fr) | Campimètre | |
| GB201100001D0 (en) | TidySqueeze2 | |
| GB201105988D0 (en) | Acid formation | |
| EP2799424A4 (fr) | Dérivé d'acide 2-fluorophénylpropionique | |
| AU4540P (en) | BUNNAN Baloskion tetraphyllum | |
| AU5171P (en) | Sunparamiho Mandevilla xamabilis | |
| AU5031P (en) | BESYS Beschorneria yuccoides | |
| AU5026P (en) | Goldstrike Agapanthus inapertus |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20230909 |